PET MPI boosts risk prediction in coronary disease

12/5/2012 | TheHeart.org (Montreal) (free registration)

A mildly abnormal stress rubidium-82 PET MPI test is linked to a 2.3 times higher risk of cardiac death compared with a normal test, indicating that PET MPI screening can boost the accuracy of risk determination in patients with coronary disease, according to a study published in the Journal of the American College of Cardiology. The study reviewed outcomes from 7,061 patients at four centers. The evaluation of the extent of ischemia and scar added to cardiac death risk reclassification in one in every nine patients in the study who had clinical PET MPI, researchers said.

View Full Article in:

TheHeart.org (Montreal) (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA